Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

R.L. Christiansen; L. Dysager; C.R. Hansen; T. Schytte; A.S. Bertelsen; H.R. Jensen; F. Mahmood; C.J. Nyborg; S. Hansen; S.N. Agergaard; O. Hansen; C. Brink; U. Bernchou

doi:10.1016/S0167-8140(22)03653-2

Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

R.L. Christiansen, L. Dysager, C.R. Hansen, T. Schytte, A.S. Bertelsen, H.R. Jensen, F. Mahmood, C.J. Nyborg, S. Hansen, S.N. Agergaard, O. Hansen, C. Brink, U. Bernchou

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	PO-1689
Tidsskrift	Radiotherapy and Oncology
Vol/bind	170
Udgave nummer	Suppl. 1
Sider (fra-til)	S1488-S1489
ISSN	0167-8140
DOI	https://doi.org/10.1016/S0167-8140(22)03653-2
Status	Udgivet - 2022
Begivenhed	European Society for Therapeutic Radiology and Oncology - København, Danmark Varighed: 6. maj 2022 → 10. maj 2022

Konference

Konference	European Society for Therapeutic Radiology and Oncology
Land/Område	Danmark
By	København
Periode	06/05/2022 → 10/05/2022

Dokumenter og links

10.1016/S0167-8140(22)03653-2

Citationsformater

Christiansen, R. L., Dysager, L., Hansen, C. R., Schytte, T., Bertelsen, A. S., Jensen, H. R., Mahmood, F., Nyborg, C. J., Hansen, S., Agergaard, S. N., Hansen, O., Brink, C., & Bernchou, U. (2022). Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy. Radiotherapy and Oncology, 170(Suppl. 1), S1488-S1489. Artikel PO-1689. https://doi.org/10.1016/S0167-8140(22)03653-2

@article{fb919dafb0c74d5698240837c2227349,

title = "Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy",

author = "R.L. Christiansen and L. Dysager and C.R. Hansen and T. Schytte and A.S. Bertelsen and H.R. Jensen and F. Mahmood and C.J. Nyborg and S. Hansen and S.N. Agergaard and O. Hansen and C. Brink and U. Bernchou",

year = "2022",

doi = "10.1016/S0167-8140(22)03653-2",

language = "English",

volume = "170",

pages = "S1488--S1489",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier",

number = "Suppl. 1",

note = "European Society for Therapeutic Radiology and Oncology ; Conference date: 06-05-2022 Through 10-05-2022",

}

Christiansen, RL, Dysager, L, Hansen, CR , Schytte, T, Bertelsen, AS, Jensen, HR, Mahmood, F , Nyborg, CJ , Hansen, S , Agergaard, SN , Hansen, O , Brink, C & Bernchou, U 2022, 'Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy', Radiotherapy and Oncology, bind 170, nr. Suppl. 1, PO-1689, s. S1488-S1489. https://doi.org/10.1016/S0167-8140(22)03653-2

TY - ABST

T1 - Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

AU - Christiansen, R.L.

AU - Dysager, L.

AU - Hansen, C.R.

AU - Schytte, T.

AU - Bertelsen, A.S.

AU - Jensen, H.R.

AU - Mahmood, F.

AU - Nyborg, C.J.

AU - Hansen, S.

AU - Agergaard, S.N.

AU - Hansen, O.

AU - Brink, C.

AU - Bernchou, U.

PY - 2022

Y1 - 2022

U2 - 10.1016/S0167-8140(22)03653-2

DO - 10.1016/S0167-8140(22)03653-2

M3 - Conference abstract in journal

SN - 0167-8140

VL - 170

SP - S1488-S1489

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Suppl. 1

M1 - PO-1689

T2 - European Society for Therapeutic Radiology and Oncology

Y2 - 6 May 2022 through 10 May 2022

ER -